— Know what they know.
Not Investment Advice

VTGN NASDAQ

VistaGen Therapeutics, Inc.
1W: +2.9% 1M: +14.2% 3M: +14.3% YTD: -58.6% 1Y: -92.1% 3Y: -94.7% 5Y: -99.7%
$0.28
-0.00 (-0.57%)
 
Weekly Expected Move ±27.4%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 54 · $12.5M mcap · 35M float · 27.98% daily turnover · Short 43% of daily vol

📊 Key Metrics

TTM
$1M
Revenue
+161.3% YoY
$-70M
Net Income
-35.5% YoY
$-67M
Free Cash Flow
-57.6% YoY
100.0%
Gross Margin
-3595.1%
Op. Margin
-3499.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-131.6%
ROA-104.9%
ROIC644.6%

Valuation

P/E-0.2
P/B0.5
EV/EBITDA0.3

Leverage

Debt/Equity0.03
Current Ratio3.67
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z-16.61
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms